Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11028)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2017 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang WW, Zhang Y, Huang XB, You N, Zheng L, Li J. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World J Gastroenterol 2017; 23(38): 6983-6994 [PMID: PMC5658316 DOI: 10.3748/wjg.v23.i38.6983] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i38/6983.htm |
| Number | Citing Articles |
| 1 |
Rui Li, Zhengsheng Mao, Xujun Ye, Tao Zuo. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021; 9(5): 1017 doi: 10.3390/microorganisms9051017
|
| 2 |
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00035
|
| 3 |
Jiangbo Cheng, Xiaoxue Zhang, Deyin Zhang, Yukun Zhang, Xiaolong Li, Yuan Zhao, Dan Xu, Liming Zhao, Wenxin Li, Jianghui Wang, Bubo Zhou, Changchun Lin, Xiaobin Yang, Rui Zhai, Panpan Cui, Xiwen Zeng, Yongliang Huang, Zongwu Ma, Jia Liu, Weimin Wang. Sheep fecal transplantation affects growth performance in mouse models by altering gut microbiota. Journal of Animal Science 2022; 100(11) doi: 10.1093/jas/skac303
|
| 4 |
Yuqing Zhou, Zhaoxia Liu, Tingtao Chen. Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.847350
|
| 5 |
Federica Di Vincenzo, Angelo Del Gaudio, Valentina Petito, Loris Riccardo Lopetuso, Franco Scaldaferri. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Internal and Emergency Medicine 2024; 19(2): 275 doi: 10.1007/s11739-023-03374-w
|
| 6 |
Jiayuan Huang, Tianyu Xu, Guoqiao Quan, Yuange Li, Xiaoya Yang, Wenrui Xie. Current progress on the microbial therapies for acute liver failure. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1452663
|
| 7 |
Danfeng Chen, Jingyi Wu, Duochen Jin, Bangmao Wang, Hailong Cao. Fecal microbiota transplantation in cancer management: Current status and perspectives. International Journal of Cancer 2019; 145(8): 2021 doi: 10.1002/ijc.32003
|
| 8 |
Robert Liptak, Barbora Gromova, Roman Gardlik. Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.665520
|
| 9 |
Antonio Gil-Gómez, Rocío Muñoz-Hernández, Filomeno Martínez, Fernando Jiménez, Manuel Romero-Gómez. Hepatic encephalopathy: experimental drugs in development and therapeutic potential. Expert Opinion on Investigational Drugs 2024; 33(12): 1219 doi: 10.1080/13543784.2024.2434053
|
| 10 |
Mohd Rabi Bazaz, Ziaur Rahman, Insha Qadir, Tulasi Pasam, Manoj P. Dandekar. Targeted Cancer Therapy in Biomedical Engineering. Biological and Medical Physics, Biomedical Engineering 2023; : 831 doi: 10.1007/978-981-19-9786-0_24
|
| 11 |
Mathias Madsen, Nina Kimer, Flemming Bendtsen, Andreas Munk Petersen. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review. Scandinavian Journal of Gastroenterology 2021; 56(5): 560 doi: 10.1080/00365521.2021.1899277
|
| 12 |
Linlin Huang, Hongdie Zhang, Yijun Liu, Yang Long. The Role of Gut and Airway Microbiota in Pulmonary Arterial Hypertension. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.929752
|
| 13 |
Jiachao Zhang, Zhaoxia Wang, Dongxue Huo, Yuyu Shao. Consumption of Goats’ Milk Protects Mice From Carbon Tetrachloride-Induced Acute Hepatic Injury and Improves the Associated Gut Microbiota Imbalance. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01034
|
| 14 |
Elina Manzhalii, Valentyna Moyseyenko, Vitalii Kondratiuk, Nataliia Molochek, Tetyana Falalyeyeva, Nazarii Kobyliak. Effect of a specific <i>Escherichia coli Nissle 1917</i> strain on minimal/mild hepatic encephalopathy treatment. World Journal of Hepatology 2022; 14(3): 634-646 doi: 10.4254/wjh.v14.i3.634
|
| 15 |
Tiziano Balzano, Marta Llansola, Yaiza M. Arenas, Paula Izquierdo-Altarejos, Vicente Felipo. Hepatic encephalopathy: investigational drugs in preclinical and early phase development. Expert Opinion on Investigational Drugs 2023; 32(11): 1055 doi: 10.1080/13543784.2023.2277386
|
| 16 |
Sung-Min Won, Ki Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Jin-Ju Jeong, Sang Jun Yoon, Min Kyo Jeong, Byeong Hyun Min, Ji Ye Hyun, Hee Jin Park, Jung A. Eom, Su Been Lee, Min Gi Cha, Goo Hyun Kwon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk. The Link between Gut Microbiota and Hepatic Encephalopathy. International Journal of Molecular Sciences 2022; 23(16): 8999 doi: 10.3390/ijms23168999
|
| 17 |
Ze Xiang, Jian Wu, Jiarui Li, Shusen Zheng, Xuyong Wei, Xiao Xu. Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation. Engineering 2023; 29: 59 doi: 10.1016/j.eng.2022.12.012
|
| 18 |
Ali Sepehrinezhad, Ali Shahbazi. Experimental and Clinical Methods in Hepatic Encephalopathy Research. Neuromethods 2025; 219: 259 doi: 10.1007/978-1-0716-4354-9_11
|
| 19 |
Kishor Pant, Senthil K. Venugopal, Maria J. Lorenzo Pisarello, Sergio A. Gradilone. The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases. The American Journal of Pathology 2023; 193(10): 1455 doi: 10.1016/j.ajpath.2023.06.007
|
| 20 |
Ali Sepehrinezhad, Ali Shahbazi. Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management. 2024; doi: 10.5772/intechopen.1004125
|
| 21 |
Agnes H. Y. Ho, Sunny Wong, Rashid Lui. Topic: Nutrition and the Gut-Liver-Brain Axis. Current Hepatology Reports 2022; 21(4): 99 doi: 10.1007/s11901-022-00589-x
|
| 22 |
Farouk K. El-Baz, Rania Elgohary, Abeer Salama, Jane Hanrahan. Amelioration of Hepatic Encephalopathy Using Dunaliella salina Microalgae in Rats: Modulation of Hyperammonemia/TLR4. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/8843218
|
| 23 |
Albert J. Czaja. Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis. Digestive Diseases and Sciences 2023; 68(7): 2824 doi: 10.1007/s10620-023-07967-5
|
| 24 |
Rashi Sehgal, Onkar Bedi, Nirupma Trehanpati. Role of Microbiota in Pathogenesis and Management of Viral Hepatitis. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00341
|
| 25 |
Wen-Rui Xie, Xiao-Ya Yang, Harry Hua-Xiang Xia, Xing-Xiang He. Fecal Microbiota Transplantation for Treating Hepatic Encephalopathy: Experimental and Clinical Evidence and Possible Underlying Mechanisms. Journal of Exploratory Research in Pharmacology 2018; 3(4): 105 doi: 10.14218/JERP.2018.00017
|
| 26 |
Maren L. Smith, James B. Wade, Jennifer Wolstenholme, Jasmohan S. Bajaj. Gut microbiome-brain-cirrhosis axis. Hepatology 2024; 80(2): 465 doi: 10.1097/HEP.0000000000000344
|
| 27 |
Yu Liu, Guangyan Li, Fayu Lu, Ziwei Guo, Shuang Cai, Taoguang Huo. Excess iron intake induced liver injury: The role of gut-liver axis and therapeutic potential. Biomedicine & Pharmacotherapy 2023; 168: 115728 doi: 10.1016/j.biopha.2023.115728
|
| 28 |
Yongmei Liu, Linda Fan, Zhuo Cheng, Lei Yu, Shuo Cong, Yaxin Hu, Lili Zhu, Baofang Zhang, Yiju Cheng, Peiling Zhao, Xueke Zhao, Mingliang Cheng. Fecal transplantation alleviates acute liver injury in mice through regulating Treg/Th17 cytokines balance. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81263-y
|
| 29 |
Sancharan Acharya, Chinnasamy Thirunavukkarasu. Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark 2024; 29(2) doi: 10.31083/j.fbl2902067
|
| 30 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Nazarii Kobyliak. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 275 doi: 10.1007/978-3-031-19564-8_10
|
| 31 |
Xiaojing Liu, Zengjin Wang, Chuanfeng Teng, Zhiping Wang. Changes in gut microbiota and metabolites of mice with intravenous graphene oxide-induced embryo toxicity. Toxicological Research 2024; 40(4): 571 doi: 10.1007/s43188-024-00242-3
|
| 32 |
Xiao-Yan Ye, Jun-Yi Chen, Li-Hao Wu, Dan-Ping Luo, Xiao-Huo Ye, Li-Quan Wu, Xing-Xiang He. Washed microbiota transplantation improves symptoms and intestinal barrier function in patients with functional bowel disorders: a propensity-score matching analysis. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03131-z
|
| 33 |
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. International Journal of Molecular Sciences 2019; 20(2): 395 doi: 10.3390/ijms20020395
|
| 34 |
G Henin, N Lanthier, G Dahlqvist. Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?. Acta Gastro Enterologica Belgica 2022; 85(4): 611 doi: 10.51821/85.4.10899
|
| 35 |
Paulraj Kanmani, Kanmani Suganya, Hojun Kim. The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases. Biomedicines 2020; 8(11): 501 doi: 10.3390/biomedicines8110501
|
| 36 |
Yusha Luo, Tingting Zhou. Connecting the dots: Targeting the microbiome in drug toxicity. Medicinal Research Reviews 2022; 42(1): 83 doi: 10.1002/med.21805
|
| 37 |
Jiachen Liu, Yantao Xu, Bimei Jiang. Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.586427
|
| 38 |
Shivdeep S. Hayer, Mackenzie Conrin, Jeffrey A. French, Andrew K. Benson, Sophie Alvarez, Kathryn Cooper, Anne Fischer, Zahraa Wajih Alsafwani, William Gasper, Mallory J. Suhr Van Haute, Haley R. Hassenstab, Shayda Azadmanesh, Missy Briardy, Skyler Gerbers, Aliyah Jabenis, Jennifer L. Thompson, Jonathan B. Clayton. Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavioral and neuroendocrine changes in a nonhuman primate model. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2305476
|
| 39 |
Teresa C. Delgado, Javier de las Heras, María L. Martínez-Chantar. Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1058101
|
| 40 |
Arghya Samanta, Moinak Sen Sarma. Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective. World Journal of Hepatology 2024; 16(5): 678-683 doi: 10.4254/wjh.v16.i5.678
|
| 41 |
Sabine Hazan. Rapid improvement in Alzheimer’s disease symptoms following fecal microbiota transplantation: a case report. Journal of International Medical Research 2020; 48(6) doi: 10.1177/0300060520925930
|
| 42 |
Yue-Qiao Chen, Jia-Ling Liu. Advances in research of microbiome regulation as a therapy for liver failure. World Chinese Journal of Digestology 2022; 30(22): 971 doi: 10.11569/wcjd.v30.i22.971
|
| 43 |
Ivana Milosevic, Edda Russo, Ankica Vujovic, Aleksandra Barac, Olja Stevanovic, Stefano Gitto, Amedeo Amedei. Microbiota and viral hepatitis: State of the art of a complex matter. World Journal of Gastroenterology 2021; 27(33): 5488-5501 doi: 10.3748/wjg.v27.i33.5488
|
| 44 |
Zhen Li, Tianning Sun, Zhigang He, Zhixiao Li, Wencui Zhang, Jie Wang, Hongbing Xiang. SCFAs Ameliorate Chronic Postsurgical Pain–Related Cognition Dysfunction via the ACSS2-HDAC2 Axis in Rats. Molecular Neurobiology 2022; 59(10): 6211 doi: 10.1007/s12035-022-02971-8
|
| 45 |
Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. Journal of Clinical and Experimental Hepatology 2020; 10(5): 477 doi: 10.1016/j.jceh.2020.04.011
|
| 46 |
Jing Li, Jinfeng Han, Juan Lv, Shiji Wang, Lai Qu, Yanfang Jiang, Carlo Gabriele Tocchetti. Saikosaponin A-Induced Gut Microbiota Changes Attenuate Severe Acute Pancreatitis through the Activation of Keap1/Nrf2-ARE Antioxidant Signaling. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/9217219
|
| 47 |
Alba Rocco, Costantino Sgamato, Debora Compare, Pietro Coccoli, Olga Maria Nardone, Gerardo Nardone. Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.748253
|
| 48 |
Weiyi Jia, Jiajia Liu, Rui Hu, Anling Hu, Weiwei Tang, Lijuan Li, Jin Li. Xiaochaihutang Improves the Cortical Astrocyte Edema in Thioacetamide-Induced Rat Acute Hepatic Encephalopathy by Activating NRF2 Pathway. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00382
|
| 49 |
Dario Spanu, Andrea Pretta, Eleonora Lai, Mara Persano, Clelia Donisi, Stefano Mariani, Marco Dubois, Marco Migliari, Giorgio Saba, Pina Ziranu, Valeria Pusceddu, Marco Puzzoni, Giorgio Astara, Mario Scartozzi. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment. World Journal of Hepatology 2022; 14(7): 1319-1332 doi: 10.4254/wjh.v14.i7.1319
|
| 50 |
Amedeo Amedei, Stefano Gitto, Claudia Campani, Fabio Marra. Probiotics. 2022; : 467 doi: 10.1016/B978-0-323-85170-1.00003-8
|
| 51 |
Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu, Guobin Wu. The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.595759
|
| 52 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Luigi Boccuto, Emidio Scarpellini, Nazarii Kobyliak, Ludovico Abenavoli. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina 2022; 58(1): 84 doi: 10.3390/medicina58010084
|
| 53 |
Kasra Mokhtarpour, Milad Akbarzadehmoallemkolaei, Nima Rezaei. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_419
|
| 54 |
Su Youn Baek, Eun Hye Lee, Tae Woo Oh, Hyun Ju Do, Kwang-Youn Kim, Kwang-Il Park, Young Woo Kim. Network Pharmacology-Based Approaches of Rheum undulatum Linne and Glycyrriza uralensis Fischer Imply Their Regulation of Liver Failure with Hepatic Encephalopathy in Mice. Biomolecules 2020; 10(3): 437 doi: 10.3390/biom10030437
|
| 55 |
Annarein J. C. Kerbert, Rajiv Jalan. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease. F1000Research 2020; 9: 312 doi: 10.12688/f1000research.22183.1
|
| 56 |
Sudhir Maharshi, Barjesh Chander Sharma. Diagnosis and Management of Hepatic Encephalopathy. 2018; : 99 doi: 10.1007/978-3-319-76798-7_7
|
| 57 |
B CHEN, Y YANG, S LI, X ZHU, Y QI, F HONG. The Critical Role of Hippocampal Dopamine in the Pathogenesis of Hepatic Encephalopathy. Physiological Research 2021; : 101 doi: 10.33549/physiolres.934563
|
| 58 |
Ruirui Zhu, Liwen Liu, Guizhen Zhang, Jianxia Dong, Zhigang Ren, Zhiqin Li. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis. Bioscience Reports 2023; 43(6) doi: 10.1042/BSR20222524
|
| 59 |
Xinpei Gu, Qin Lu, Chengcheng Zhang, Zhewei Tang, Liuxi Chu. Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review. Seminars in Liver Disease 2021; 41(04): 495 doi: 10.1055/s-0041-1732319
|
| 60 |
Jiaxin Zhang, Xiaobin Zao, Jiaying Zhang, Ziwei Guo, Qian Jin, Guang Chen, Da'nan Gan, Hongbo Du, Yong'an Ye. Is it possible to intervene early cirrhosis by targeting toll-like receptors to rebalance the intestinal microbiome?. International Immunopharmacology 2023; 115: 109627 doi: 10.1016/j.intimp.2022.109627
|
| 61 |
Lijun Wang, Yu-Jui Yvonne Wan. The role of gut microbiota in liver disease development and treatment. Liver Research 2019; 3(1): 3 doi: 10.1016/j.livres.2019.02.001
|
| 62 |
Jingguo Li, Biguang Tuo, Stefano Gitto. Current and Emerging Approaches for Hepatic Fibrosis Treatment. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/6612892
|
| 63 |
Reham M. Essam, Mariam A. Saadawy, Mahitab Gamal, Rania M. Abdelsalam, Ayman E. El-Sahar. Lactoferrin averts neurological and behavioral impairments of thioacetamide-induced hepatic encephalopathy in rats via modulating HGMB1/TLR-4/MyD88/Nrf2 pathway. Neuropharmacology 2023; 236: 109575 doi: 10.1016/j.neuropharm.2023.109575
|
| 64 |
Yash R Shah, Hassam Ali, Angad Tiwari, David Guevara-Lazo, Natalia Nombera-Aznaran, Bhanu Siva Mohan Pinnam, Manesh Kumar Gangwani, Harishankar Gopakumar, Amir H Sohail, SriLakshmiDevi Kanumilli, Ernesto Calderon-Martinez, Geetha Krishnamoorthy, Nimish Thakral, Dushyant Singh Dahiya. Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions. World Journal of Hepatology 2024; 16(1): 17-32 doi: 10.4254/wjh.v16.i1.17
Abstract(433) |
Core Tip(376) |
Full Article(HTML)(3811)
|
Full Article with Cover (PDF)-12399K(133)
|
Full Article (Word)-905K(33)
|
Audio-1259K(4)
|
Peer-Review Report-216K(57)
|
Answering Reviewers-145K(53)
|
Full Article (PDF)-1655K(177)
|
Full Article (XML)-226K(52)
|
Times Cited (8)
|
Total Visits (6383)
|
Open
|
| 65 |
Dongxin Yi, Tao Li, Yuji Xiao, Xue Zhang, Qiangqiang Hao, Feng Zhang, Tianming Qiu, Guang Yang, Xiance Sun, Ying Dong, Ningning Wang. Fecal microbiota transplantation for the treatment of intestinal and extra‐intestinal diseases: Mechanism basis, clinical application, and potential prospect. Bioengineering & Translational Medicine 2024; doi: 10.1002/btm2.10728
|
| 66 |
Mengying Xi, Qijun Ruan, Sulan Zhong, Jiatong Li, Weijuan Qi, Congman Xie, Xiaoyan Wang, Nuerbiya Abuduxiku, Jia Ni. Periodontal bacteria influence systemic diseases through the gut microbiota. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1478362
|
| 67 |
Zhihao Qu, Peijun Tian, Bo Yang, Jianxin Zhao, Gang Wang, Wei Chen. Fecal microbiota transplantation for diseases: Therapeutic potential, methodology, risk management in clinical practice. Life Sciences 2022; 304: 120719 doi: 10.1016/j.lfs.2022.120719
|
| 68 |
Amit Kumar Ram, Gavin Wright, Balasubramaniyan Vairappan. Liver Pathology. 2021; doi: 10.5772/intechopen.89578
|
| 69 |
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease. Metabolites 2023; 13(6): 772 doi: 10.3390/metabo13060772
|
| 70 |
Marina Romaní-Pérez, María del Carmen Cenit, Ana Agustí. Experimental and Clinical Methods in Hepatic Encephalopathy Research. Neuromethods 2025; 219: 227 doi: 10.1007/978-1-0716-4354-9_10
|
| 71 |
Cassandra E. Gheorghe, Nathaniel L. Ritz, Jason A. Martin, Hannah R. Wardill, John F. Cryan, Gerard Clarke. Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1941711
|
| 72 |
Yan-Chao Hu, Xiang-Chun Ding, Hui-Juan Liu, Wan-Long Ma, Xue-Yan Feng, Li-Na Ma. Effects of <i>Lactobacillus paracasei</i> N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis. World Journal of Gastroenterology 2024; 30(11): 1556-1571 doi: 10.3748/wjg.v30.i11.1556
|
| 73 |
Rachna Gupta, Muktika Tekade, Nupur Vasdev, Tanisha Gupta, Bhakti Pawar, Kuldeep Kumar Bansal, Rakesh Kumar Tekade. Essentials of Pharmatoxicology in Drug Research, Volume 1. 2023; : 317 doi: 10.1016/B978-0-443-15840-7.00006-3
|
| 74 |
Priyankar Dey. The role of gut microbiome in chemical-induced metabolic and toxicological murine disease models. Life Sciences 2020; 258: 118172 doi: 10.1016/j.lfs.2020.118172
|
| 75 |
Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Luca Miele. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. International Journal of Molecular Sciences 2021; 22(12): 6485 doi: 10.3390/ijms22126485
|
| 76 |
Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Parika Kalra, Chintan Patel, Pankaj Desai, Krishna Parekh. Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy—A case series. Indian Journal of Gastroenterology 2018; 37(6): 559 doi: 10.1007/s12664-018-0906-1
|
| 77 |
Bingjie Lu, Chao Wu, Nisma Lena Bahaji Azami, Dong Xie, Changqing Zhao, Wan Xu, Dengcheng Hui, Xi Chen, Runfei Sun, Jingru Song, Yongtong An, Kun Li, Huijun Wang, Guan Ye, Mingyu Sun. Babao Dan improves neurocognitive function by inhibiting inflammation in clinical minimal hepatic encephalopathy. Biomedicine & Pharmacotherapy 2021; 135: 111084 doi: 10.1016/j.biopha.2020.111084
|
| 78 |
Sonia Bouri, Ailsa Hart. Fecal microbial transplantation. Current Opinion in Clinical Nutrition & Metabolic Care 2018; 21(5): 405 doi: 10.1097/MCO.0000000000000488
|
| 79 |
E. Yu. Plotnikova, M. N. Sinkova, L. K. Isakov. Asthenia and fatigue in hyperammonemia: etiopathogenesis and methods of correction. Meditsinskiy sovet = Medical Council 2022; (21-1): 95 doi: 10.21518/2079-701X-2021-21-1-95-104
|
| 80 |
Chunchun Yuan, Jinghui Fan, Lai Jiang, Wenxin Ye, Zhuo Chen, Wenzi Wu, Qixin Huang, Lichun Qian. Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice. Nutrients 2023; 15(5): 1149 doi: 10.3390/nu15051149
|
| 81 |
Jie Gao, Rui Nie, Hong Chang, Wei Yang, Qian Ren. A meta-analysis of microbiome therapies for hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2023; 35(9): 927 doi: 10.1097/MEG.0000000000002596
|
| 82 |
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020; 9(4): 875 doi: 10.3390/cells9040875
|
| 83 |
K. S. Gala, E. Winrich, S. K. Jha, R. Parthasarathy, V. Vatsalya. Alcohol Use Disorder and the Gut Microbiome. Current Addiction Reports 2023; 11(1): 105 doi: 10.1007/s40429-023-00527-x
|
| 84 |
Antea Krsek, Lara Baticic. Neutrophils in the Focus: Impact on Neuroimmune Dynamics and the Gut–Brain Axis. Gastrointestinal Disorders 2024; 6(3): 557 doi: 10.3390/gidisord6030039
|
| 85 |
Mar Moreno-Gonzalez, Naiara Beraza. The Role of the Microbiome in Liver Cancer. Cancers 2021; 13(10): 2330 doi: 10.3390/cancers13102330
|
| 86 |
Hanna Antushevich. Fecal microbiota transplantation in disease therapy. Clinica Chimica Acta 2020; 503: 90 doi: 10.1016/j.cca.2019.12.010
|
| 87 |
Emilio Merlo Pich, Ioannis Tarnanas, Patrizia Brigidi, Ginetta Collo. Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches.. Neurobiology of Stress 2025; : 100713 doi: 10.1016/j.ynstr.2025.100713
|
| 88 |
Francesca Romana Ponziani, Alberto Nicoletti, Antonio Gasbarrini, Maurizio Pompili. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2019; 11 doi: 10.1177/1758835919848184
|